Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-03-01 @ 12:04 PM
Study NCT ID:
NCT03638167
Status:
COMPLETED
Last Update Posted:
2025-12-17
First Post:
2018-08-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Sponsor:
Seattle Children's Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Central Nervous System Tumor, Pediatric | View |
| None | Glioma | View |
| None | Ependymoma | View |
| None | Medulloblastoma | View |
| None | Germ Cell Tumor | View |
| None | Atypical Teratoid/Rhabdoid Tumor | View |
| None | Primitive Neuroectodermal Tumor | View |
| None | Choroid Plexus Carcinoma | View |
| None | Pineoblastoma | View |